Nasopharyngeal teratoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:141107D10.6
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Nasopharyngeal teratoma is a rare congenital germ cell tumor that arises in the nasopharynx (the upper part of the throat behind the nose). Teratomas are tumors composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain elements such as skin, hair, teeth, bone, cartilage, and neural tissue. When located in the nasopharynx, these tumors are also sometimes referred to as epignathus when they protrude from the oral cavity or palate, though nasopharyngeal teratoma more specifically refers to masses arising within or projecting into the nasopharyngeal space. The ICD-10 classification D10.6 indicates a benign neoplasm of the nasopharynx. Nasopharyngeal teratomas are typically diagnosed at birth or prenatally via ultrasound, as they can cause significant airway obstruction, feeding difficulties, and respiratory distress in neonates. Key clinical features include nasal obstruction, difficulty breathing, inability to feed, and a visible or palpable mass in the oral cavity or nasopharynx. In severe cases, large tumors detected prenatally may cause polyhydramnios (excess amniotic fluid) due to impaired fetal swallowing. The condition primarily affects the upper aerodigestive tract and can secondarily impact respiratory and nutritional status. Treatment is primarily surgical excision, which is often curative for mature (benign) teratomas. The surgical approach depends on the size and extent of the tumor and may range from transoral resection to more complex craniofacial procedures. Most nasopharyngeal teratomas are histologically mature and benign, carrying an excellent prognosis after complete surgical removal. However, careful histological examination is essential to rule out immature or malignant components, which would require additional treatment. Prenatal planning, including the EXIT (Ex Utero Intrapartum Treatment) procedure to secure the airway during delivery, may be necessary for large tumors identified before birth.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Nasopharyngeal teratoma.

View clinical trials →

No actively recruiting trials found for Nasopharyngeal teratoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Nasopharyngeal teratoma community →

Specialists

2 foundView all specialists →
SP
Sandip P Patel
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Nasopharyngeal teratoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nasopharyngeal teratomaForum →

No community posts yet. Be the first to share your experience with Nasopharyngeal teratoma.

Start the conversation →

Latest news about Nasopharyngeal teratoma

No recent news articles for Nasopharyngeal teratoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Nasopharyngeal teratoma

What is Nasopharyngeal teratoma?

Nasopharyngeal teratoma is a rare congenital germ cell tumor that arises in the nasopharynx (the upper part of the throat behind the nose). Teratomas are tumors composed of tissues derived from all three embryonic germ layers — ectoderm, mesoderm, and endoderm — and may contain elements such as skin, hair, teeth, bone, cartilage, and neural tissue. When located in the nasopharynx, these tumors are also sometimes referred to as epignathus when they protrude from the oral cavity or palate, though nasopharyngeal teratoma more specifically refers to masses arising within or projecting into the nas

How is Nasopharyngeal teratoma inherited?

Nasopharyngeal teratoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Nasopharyngeal teratoma typically begin?

Typical onset of Nasopharyngeal teratoma is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Nasopharyngeal teratoma?

2 specialists and care centers treating Nasopharyngeal teratoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.